Japanese Encephalitis Vaccine Launched in India

by Kathy Jones on  September 14, 2012 at 8:53 PM Indian Health News
RSS Email Print This Page Comment
Font : A-A+

Austrian biotech company Intercell announced the launch of its Japanese encephalitis vaccine in India where it will be manufactured by its partner, Biological E in Hyderabad.
 Japanese Encephalitis Vaccine Launched in India
Japanese Encephalitis Vaccine Launched in India

The vaccine will be marketed under the brand name Jeev and will cost around Rs 985. Intercell revealed that it hoped the launch will help the company achieve a profit in the second quarter and added that it was also looking get approval to market the vaccine in other Asian countries.

Jeev is already available in western markets including Europe, North America, Australia and Singapore where it is marketed under the brand name Ixario.

Stating that it was a major step forward for his company, Intercell Chief Executive Thomas Lingelbach said, "We have taken a major step forward in achieving our goal of rolling out this Japanese Encephalitis vaccine in endemic countries with a high medical need in order to protect children and adults."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Japanese Encephalitis Meningitis Cat Scratch Disease Vaccination for Children Zika Fever Top 10 Vaccine Myths Debunked Encephalitis Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive